Clinical study - Hématologie Lymphome non Hodgkinien

REALYSA
Hématologie Lymphome non Hodgkinien
Ouvert depuis le: 09.28.2021
Site: Paris
Ouvert depuis le: 02.11.2021
Site: Saint-Cloud
Public cible
Adulte
REALYSA;REAL WORLD DATA IN LYMPHOMA AND;SURVIVAL IN ADULTS
Description de l'essai

As the number of cancer survivors continues to grow [1,2], research investigating the factors that affect cancer outcomes, such as disease recurrence, risk of second malignant neoplasms, and the late effects of cancer treatments, becomes ever more important. In parallel, numerous epidemiologic studies have investigated factors that affect cancer risk, but far fewer have addressed the extent to which socioeconomic status, social institutional context (i.e. healthcare system), social relationships, environmental context (exposures), and individual behaviors (lifestyle) influence cancer outcomes [3]. Critical factors in addition to treatment that have been documented to influence outcomes in these groups of diseases are needed (e.g. age, gender, comorbidities, and some lifestyle factors), together with biospecimens for molecular and other type of biomarker measures that may predict outcomes. The ultimate goal of delineating the influence of these factors is to improve the medical management of cancer patients.